Patients with history of preeclampsia have increased risk for myocardial infarction and worse myocardial infarction outcomes.

Shifting patterns in ischemic stroke mortality and death locations across US populations highlight disparities and end-of-life care needs.

Compounded vs non-compounded GLP-1 RA drug products are associated with an increased risk for adverse events such as nausea and diarrhea.